Video Experimental Relacionado
Updated: Feb 15, 2026
10:35
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
4.0K
Anticorpos definidos químicamente y conjugados de fármacos de moléculas pequeñas para aplicaciones dirigidas a
Samuele Cazzamalli1, Alberto Dal Corso1, Fontaine Widmayer1
1Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich) , Vladimir-Prelog-Weg 4, CH-8093 Zurich, Switzerland.
Journal of the American Chemical Society
|January 18, 2018
Resumen
Este estudio compara los conjugados anticuerpo-medicamento y los conjugados de moléculas pequeñas para el tratamiento del cáncer. Ambos tipos de fármacos se dirigen a la anhidrase carbónica IX, un marcador para la hipoxia tumoral y el carcinoma de células renales.
Área de la Ciencia:
- En el campo de la oncología
- Farmacología
- La bioquímica
Sus antecedentes:
- La anidrasa carbónica IX (CA IX) es un biomarcador validado para la hipoxia tumoral.
- CA IX está altamente expresado en el carcinoma renal de células claras (CCRCC).
- Las terapias dirigidas son cruciales para el tratamiento eficaz del cáncer.
Objetivo del estudio:
- Para comparar directamente la eficacia de un conjugado anticuerpo-medicamento (ADC) y un conjugado de molécula pequeña-medicamento (SMDC).
- Evaluar estos conjugados dirigidos a la anhidrasa carbónica IX (CA IX).
- Evaluar su potencial terapéutico para el cáncer, en particular para el carcinoma de células renales.
Principales métodos:
- Desarrollo de ADC y SMDC químicamente definidos dirigidos a CA IX.
- Estudios comparativos in vitro y in vivo.
- Evaluación de la afinidad de unión y la eficacia terapéutica.
Principales resultados:
- Tanto el ADC como el SMDC demostraron una alta afinidad de unión al CA IX.
- Se generaron datos comparativos sobre la eficacia terapéutica del ADC frente al SMDC.
- El estudio proporciona una evaluación directa de estos dos tipos conjugados.
Conclusiones:
- Los conjugados anticuerpo-fármaco y los conjugados de moléculas pequeñas representan estrategias terapéuticas viables dirigidas a CA IX.
- Esta evaluación comparativa sirve de base para el desarrollo de nuevas terapias dirigidas al cáncer.
- Se requiere más investigación para optimizar estos conjugados para su aplicación clínica en el carcinoma de células renales y otros tumores que expresan CA IX.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:50Conjugated Proteins
29.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.2K
01:20Comparing the Survival Analysis of Two or More Groups
619
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
619
02:38Molecules and Compounds
69.8K
Atoms and Molecules
69.8K
03:10Chemical Equations
82.3K
Chemical equations represent the identities and relative quantities of substances involved in a chemical reaction. The substances undergoing reaction are called reactants, and their formulas are placed on the left side of the equation. The substances generated by the reaction are called products, and their formulas are placed on the right side of the equation. Plus signs (+) separate individual reactant and product formulas, and an arrow (→) separates the reactant and product (left and right)...
82.3K
01:21Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
792
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
792
01:26Targets for Drug Action: Overview
10.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K